from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2896c/-

LFCtreatmentdescriptionclass of inhibitor

0.010

Amikacinug/mL Amikacintranslation

1.035

Cap5-10ug/mL Capreomycintranslation

-0.538

Rox10-50 ug/mL Roxithromycintranslation

-0.229

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.287

Rif0.2-5ug/mL Rifampicintranscription

-0.059

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.553

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.340

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.122

CPZ10-50 ug/mL Chlorpromazinerespiration

0.993

Clofazimine10-13 ug/mL Clofaziminerespiration

0.345

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.189

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.181

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.194

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.663

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.873

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.878

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.089

Nigericin50 uM Nigericinrespiration

-0.432

TRC10-150 ug/mL Triclosanrespiration

0.948

TRZ10-25 ug/mL Thioridazinerespiration

-0.117

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.875

menadione6-10 ug/mL Menadionerespiration

-0.242

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.039

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.253

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.038

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.834

NRP_1Non-replicating persistence stage 1dosRassociated

-0.469

Amp0.2mg/mL AmpicillincellWall

0.562

Cephalexin20-100 ug/mL CephalexincellWall

2.145

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.482

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.385

EMB10-20 ug/mL EthambutolcellWall

-0.321

Eta12-40 ug/mL EthionamidecellWall

-0.413

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.036

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.593

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.613

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

BZA0.12 mg/mL BenzamidearomaticAmides

0.521

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.148

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.048

H2O24 mM hydrogen peroxideDNAdamaging

-0.164

Levo10 ug/mL LevofloxacinDNAdamaging

0.043

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.321

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.011

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.053

UVUV-irradiationDNAdamaging

0.665

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.353

Antimycin12.5-50 ug/mL Antimycin A?

-2.126

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.886

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.432

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.206

PA8240.2-2 ug/mL PA-824?

0.391

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.027

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.344

Verapamil50 uM Verapamil?

-0.910

mercaptoethanol2 mM 2-Mercaptoethanol?

0.155

methoxatin10-20 ug/mL Methoxatin?